Stock 6615 SOFIVA GENOMICS CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Sofiva Genomics Co.,Ltd.

Equities

6615

TW0006615008

Biotechnology & Medical Research

End-of-day quote Taipei Exchange
Other stock markets
 03:30:00 28/06/2024 am IST 		5-day change 1st Jan Change
79.9 TWD +7.97% Intraday chart for Sofiva Genomics Co.,Ltd. +30.77% +94.88%
15/05 Sofiva Genomics Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
18/03 Sofiva Genomics Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 1,869 1,500 1,093 1,042 784 875.9
Enterprise Value (EV) 1 1,569 1,361 974.8 882.6 687.7 799.4
P/E ratio 39.7 x 24.3 x 31.8 x 18.3 x 18.4 x 76 x
Yield 2.26% 3.67% 2.72% 4.08% 2.72% 0.49%
Capitalization / Revenue 4.07 x 2.94 x 2.24 x 2.05 x 1.58 x 1.88 x
EV / Revenue 3.42 x 2.67 x 1.99 x 1.74 x 1.39 x 1.71 x
EV / EBITDA 20.5 x 14.6 x 18.7 x 14.6 x 23 x 78.3 x
EV / FCF 89.6 x 19.2 x 28.6 x 13.9 x -33.7 x 300 x
FCF Yield 1.12% 5.2% 3.5% 7.21% -2.97% 0.33%
Price to Book 3.79 x 2.92 x 1.98 x 1.68 x 1.25 x 1.42 x
Nbr of stocks (in thousands) 21,090 21,159 21,219 21,262 21,362 21,362
Reference price 2 88.60 70.90 51.50 49.00 36.70 41.00
Announcement Date 01/04/19 31/03/20 31/03/21 24/03/22 31/03/23 18/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 459.4 509.4 488.9 508.4 495.8 466.8
EBITDA 1 76.66 93.47 52.19 60.4 29.85 10.21
EBIT 1 54.07 66.72 20.92 35.24 3.787 -15.88
Operating Margin 11.77% 13.1% 4.28% 6.93% 0.76% -3.4%
Earnings before Tax (EBT) 1 52.04 75.22 37.28 63.69 47.35 8.903
Net income 1 47.35 62.67 34.62 56.98 42.78 11.53
Net margin 10.31% 12.3% 7.08% 11.21% 8.63% 2.47%
EPS 2 2.232 2.920 1.620 2.677 2.000 0.5396
Free Cash Flow 1 17.51 70.82 34.08 63.61 -20.41 2.664
FCF margin 3.81% 13.9% 6.97% 12.51% -4.12% 0.57%
FCF Conversion (EBITDA) 22.84% 75.77% 65.31% 105.32% - 26.08%
FCF Conversion (Net income) 36.98% 113% 98.45% 111.65% - 23.11%
Dividend per Share 2 2.000 2.600 1.400 2.000 1.000 0.2000
Announcement Date 01/04/19 31/03/20 31/03/21 24/03/22 31/03/23 18/03/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3
Net sales 1 - 129.6 120
EBITDA - - -
EBIT 1 - 2.143 -4.01
Operating Margin - 1.65% -3.34%
Earnings before Tax (EBT) 1 - 7.98 1.869
Net income 1 14.31 5.92 2.548
Net margin - 4.57% 2.12%
EPS 2 0.6700 0.2800 0.1200
Dividend per Share - - -
Announcement Date 05/05/22 03/08/22 09/11/22
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 300 139 118 159 96.3 76.4
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 17.5 70.8 34.1 63.6 -20.4 2.66
ROE (net income / shareholders' equity) 11.9% 12.3% 6.41% 9.64% 6.89% 1.91%
ROA (Net income/ Total Assets) 6.92% 6.38% 1.78% 2.8% 0.29% -1.26%
Assets 1 684.3 982.9 1,950 2,036 14,730 -914.3
Book Value Per Share 2 23.40 24.20 26.00 29.20 29.30 28.90
Cash Flow per Share 2 14.20 11.50 8.880 10.10 5.610 4.530
Capex 1 27.8 18 15.5 8.16 33.5 21
Capex / Sales 6.05% 3.54% 3.16% 1.61% 6.76% 4.5%
Announcement Date 01/04/19 31/03/20 31/03/21 24/03/22 31/03/23 18/03/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly earnings - Rate of surprise

Company calendar

Sector Bio Diagnostics & Testing

1st Jan change Capi.
SOFIVA GENOMICS CO.,LTD. Stock Sofiva Genomics Co.,Ltd.
+94.88% 52.54M
EXACT SCIENCES CORPORATION Stock Exact Sciences Corporation
-42.89% 7.8B
GUARDANT HEALTH, INC. Stock Guardant Health, Inc.
+6.77% 3.53B
IOVANCE BIOTHERAPEUTICS, INC. Stock Iovance Biotherapeutics, Inc.
-1.35% 2.24B
BGI GENOMICS CO., LTD. Stock BGI Genomics Co., Ltd.
-27.06% 1.84B
VERACYTE, INC. Stock Veracyte, Inc.
-21.23% 1.66B
MARAVAI LIFESCIENCES HOLDINGS, INC. Stock Maravai LifeSciences Holdings, Inc.
+9.31% 951M
CAREDX, INC Stock CareDx, Inc
+29.42% 811M
SEEGENE, INC. Stock Seegene, Inc.
-12.66% 670M
ADAPTIVE BIOTECHNOLOGIES CORPORATION Stock Adaptive Biotechnologies Corporation
-26.12% 533M
Bio Diagnostics & Testing
  1. Stock Market
  2. Equities
  3. 6615 Stock
  4. Financials Sofiva Genomics Co.,Ltd.